Search hospitals > Colorado > Denver
Porter Adventist Hospital
Claim this profileDenver, Colorado 80210
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Cancer
Conducts research for Prostate Cancer
388 reported clinical trials
5 medical researchers
Summary
Porter Adventist Hospital is a medical facility located in Denver, Colorado. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Prostate Cancer and other specialties. Porter Adventist Hospital is involved with conducting 388 clinical trials across 499 conditions. There are 5 research doctors associated with this hospital, such as Richard L. Deming, Shahzad Siddique, Douglas Dennis, MD, and Mohammed Salhab.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
2Lung Cancer
Global LeaderStage IV
Stage II
Stage I
Top PIs
Richard L. DemingMercy Medical Center - Des Moines6 years of reported clinical research
Expert in Breast Cancer
Expert in Cancer
178 reported clinical trials
242 drugs studied
Shahzad SiddiquePenrose-Saint Francis Healthcare2 years of reported clinical research
Expert in Breast Cancer
Expert in Cancer
124 reported clinical trials
187 drugs studied
Douglas Dennis, MDColorado Joint Replacement3 years of reported clinical research
Studies Osteoarthritis
Studies Traumatic Arthropathy
6 reported clinical trials
9 drugs studied
Mohammed SalhabParker Adventist Hospital2 years of reported clinical research
Studies Squamous Cell Carcinoma
Studies Non-Small Cell Lung Cancer
3 reported clinical trials
10 drugs studied
Clinical Trials running at Porter Adventist Hospital
Lung Cancer
Bladder Cancer
Prostate Cancer
Breast Cancer
Multiple Myeloma
Pancreatic Cancer
Esophageal cancer
Melanoma
Bladder Carcinoma
Breast cancer
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Porter Adventist Hospital?
Porter Adventist Hospital is a medical facility located in Denver, Colorado. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Prostate Cancer and other specialties. Porter Adventist Hospital is involved with conducting 388 clinical trials across 499 conditions. There are 5 research doctors associated with this hospital, such as Richard L. Deming, Shahzad Siddique, Douglas Dennis, MD, and Mohammed Salhab.
Where is Porter Adventist Hospital located?
Porter Adventist Hospital is located at 2525 S Downing St, Denver, CO 80210.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Porter Adventist Hospital, contact the Patient Financial Services department at (802) 847-8000 or 800-639-2719, available Monday-Friday, 8:30 a.m. – 4 p.m. They provide financial assistance programs, eligibility assessment for government funding, and financial hardship treatment options. The hospital accepts various insurance plans, including Aetna, Blue Cross Blue Shield of Vermont, Cigna, Medicaid, Medicare, MVP, and United HealthCare; however, verify your plan's coverage directly with the hospital.
What insurance does Porter Adventist Hospital accept?
Porter Adventist Hospital, a member of Centura Health, accepts Cigna insurance plans. The hospital also accepts Medicare, Medicaid, various commercial managed care plans, exchange plans, and worker's compensation plans. It is recommended to contact the hospital directly to confirm the current accepted insurance plans.
What awards or recognition has Porter Adventist Hospital received?
Porter Adventist Hospital, located in Denver, Colorado, has earned Magnet™ Recognition from the American Nurses Credentialing Center, highlighting its excellence in nursing services. It is also recognized as one of America's highest-rated hospitals for patient safety by The Leapfrog Group.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.